Condor Capital Management Clene Inc. Transaction History

Condor Capital Management

  • $1.09 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$0.46 - $0.87 $20,833 - $39,402
-45,290 Reduced 43.83%
58,046 $29,000
Q2 2023

Aug 10, 2023
SELL
$0.78 - $1.22 $48,750 - $76,250
-62,500 Reduced 37.69%
103,336 $90,000
Q1 2023

May 10, 2023
BUY
$0.95 - $1.62 $157,544 - $268,654
165,836 New
165,836 $187,000

Others Institutions Holding CLNN

# of Institutions
6
Shares Held
230K
Call Options Held
0
Put Options Held
25K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $273M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Condor Capital Management Portfolio

Follow Condor Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Condor Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Condor Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email